论文部分内容阅读
AIM: Genetic polymorphisms of drug-metabolizing enzymes have recently been shown to affect susceptibility to chemical carcinogenesis. Cytochrome P450 2E1 (CYP2E1)enzyme catalyzes the metabolism of many procarcinogens,such as N-nitrosamines and related com